BetterLife Pharma Inc. (CSE:BETR)

Canada flag Canada · Delayed Price · Currency is CAD
0.0950
0.00 (0.00%)
Jul 18, 2025, 3:52 PM EDT
-36.67%
Market Cap15.56M
Revenue (ttm)n/a
Net Income (ttm)-1.78M
Shares Outn/a
EPS (ttm)-0.01
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume15,000
Average Volume23,722
Open0.0950
Previous Close0.0950
Day's Range0.0950 - 0.0950
52-Week Range0.0800 - 0.1950
Beta1.53
RSI50.79
Earnings DateJul 3, 2025

About BetterLife Pharma

BetterLife Pharma Inc., a biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight viral infections. The company’s products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to treat benz... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 7
Stock Exchange Canadian Securities Exchange
Ticker Symbol BETR
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.